Not Yet Recruiting
Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer
NCT07552181
- Conditions
- Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
- Locations
-
- Cedars-Sinai Medical Center Beverly Hills Beverly Hills, California, United States
- CS Cancer at Valley Oncology Medical Group Tarzana, California, United States
- Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States